Friday, July 31, 2026

CSIS States North Korea’s Denuclearization is Not an Achievable Short-term Goal

Victor Cha argues that North Korea's denuclearization is unattainable in the short term, suggesting a cold peace strategy instead.

WEMIX Listed on Kraken: What This Means for Global Cryptocurrency Investors

WEMIX is now listed on Kraken, enhancing its liquidity and visibility in Western markets as WeMade plans further expansion.

Banana Chip Recall: Excessive Pesticide Forces South Korean Ministry to Act

Korea's Ministry of Food and Drug Safety recalls banana chips due to excessive pesticide levels, urging consumers to return affected products.

Tag: Yuflyma

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.